Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study

Affiliations

• ¹ Department of Neurobiology, Care Sciences and Society, Neurogeriatrics, Karolinska Institute, Stockholm, Sweden linn.oijerstedt@ki.se.
• ² Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Stockholm, Sweden.
• ³ Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
• ⁴ Department of Medical Psychology, Karolinska University Hospital, Stockholm, Sweden.
• ⁵ Department of Neurobiology, Care Sciences and Society, Neurogeriatrics, Karolinska Institute, Stockholm, Sweden.
• ⁶ Neurology, Erasmus MC, Rotterdam, Netherlands.
• ⁷ Centre for Ageing Brain and Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
• ⁸ Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic de Barcelona, Barcelona, Spain.
• ⁹ Cognitive Disorders Unit, Department of Neurology, Donosti, Donostia San Sebastian, Spain.
• ¹⁰ Neuroscience Area, Biodonostia Health Research Institute, Donostia San Sebastian, Spain.
• ¹¹ Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Faculté de Médecine, CHU de Quebec-Universite Laval, Montreal, Quebec, Canada.
• ¹² Department of Neurodegenerative Diseases, Univeristy of Tübingen, Eberhard Karls University Tubingen Hertie Institute for Clinical Brain Research, Tubingen, Germany.
• ¹³ German Centre for Neurodegenerative Diseases, Tübingen, Germany.
• ¹⁴ Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milano, Italy.
• ¹⁵ Centro Dino Ferrari, University of Milan, Milano, Italy.
• ¹⁶ Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
• ¹⁷ Sunnybrook Research Insitute, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
• ¹⁸ Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, Ontario, Canada.
• ¹⁹ Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.
• ²⁰ Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
• ²¹ Neurology Service, KU Leuven University Hospitals Leuven, Leuven, Belgium.
• ²² Faculty of Medicine, University of Lisbon, Lisboa, Portugal.
• ²³ Fondazione IRCCS, Istituto Nazionale Neurologico Carlo Besta, Milano, Italy.
• ²⁴ Neurology Service, Faculty of Medicine, Hospital and University Centre of Coimbra, Coimbra, Portugal.
• ²⁵ Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
• ²⁶ Department of Psychiatry, McGill University Health Centre, Montreal, Quebec, Canada.
• ²⁷ McConnel Brain Imaging Centre, Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada.
• ²⁸ Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.
• ²⁹ Brain Sciences, Imperial College London, London, UK.
• ³⁰ Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.
• ³¹ Geriatric Medicine and Nuclear Medicine, University of Duisburg-Essen, Duisburg, Germany.
• ³² Neurologische Klinik, Ludwig Maximilians University Munich, Munchen, Germany.
• ³³ German Centre for Neurodegenerative Diseases, Münich, Germany.
• ³⁴ Neurology, University of Ulm, Ulm, Germany.
• ³⁵ IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
• ³⁶ Molecular Markers Lab, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
• ³⁷ Neurofarba, University of Florence, Firenze, Italy.
• ³⁸ IRCCS Firenze, Fondazione Don Carlo Gnocchi Onlus, Firenze, Italy.
• ³⁹ Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.